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Objective: To determine whether exposures to infectious illness during childhood involving the CNS or else-
where is associated with adult schizophrenia or other psychoses.
Method: Systematic review and meta-analysis of published literature identiﬁed by electronic and manual
search meeting three inclusion criteria: population-base, objective assessment of childhood infection at the
individual level, standard deﬁnition of adult psychotic outcomes. We calculated risk ratio for all CNS infec-
tion, and separately for viral and bacterial infection in relation to non-affective psychosis and schizophrenia,
which was combined in meta-analysis.
Results: Seven studies were included. Meta-analysis involving 2424 cases and over 1.2 million controls
showed CNS viral infection was associated with nearly two-fold increased risk of adult non-affective psycho-
sis (risk ratio 1.70; 95% CI 1.13–2.55; p=0.01). There was no signiﬁcant heterogeneity between studies
(p=0.26; I2=20%). Separate meta-analysis involving 1035 cases and over 1.2 million controls suggested
all childhood CNS infections, particularly viral infections, may be associated with nearly two-fold risk of
adult schizophrenia. However, there was evidence of some heterogeneity between these studies (p=0.07;
I2=70%). CNS bacterial infections were not associated with risk of psychosis. Data on childhood infections
with no obvious involvement of the CNS is insufﬁcient.
Conclusions: These ﬁndings indicate childhood CNS viral infections increase the risk of adult psychotic illness.
Possible mechanisms may include both direct effects of pathogens, and the effects of inﬂammatory response
on the developing brain.© 2012 Elsevier B.V. Open access under CC BY license. 1. Introduction
Interference with brain development from early life infections is in
line with a neurodevelopmental view of schizophrenia where abnor-
malities in early brain development contribute to the causes of the
disorder (Murray and Lewis, 1987; Weinberger, 1987). Empirical evi-
dence for the relevance of abnormal neurodevelopment comes from
birth cohort studies demonstrating delays in motor milestone, and deﬁ-
cits in premorbid cognitive function in future cases of schizophrenia
(Jones et al., 1994; Cannon et al., 2000; Cannon et al., 2002a;
Khandaker et al., 2011a). So far, studies have linked exposure to a wide
range of prenatal maternal infections (and inﬂammatory response) toInternational Classiﬁcation of
tal Disorders; 95% CI, 95% Con-
niversity of Cambridge, Box 189,
4 1223 768510; fax: +44 1223
andaker).
 license. risk of schizophrenia in adult offspring (Brown and Derkits, 2010;
Khandaker et al., 2012).
The human brain continues to develop throughout childhood and
well into early adulthood (de Graaf-Peters and Hadders-Algra, 2006).
Several studies have investigated the effects of infectious illness, par-
ticularly that of the central nervous system (CNS), in early years of
life, in relation to adult schizophrenia (Rantakallio et al., 1997;
Leask et al., 2002; Suvisaari et al., 2003; Koponen et al., 2004;
Abrahao et al., 2005; Dalman et al., 2008;Weiser et al., 2010). Howev-
er, ﬁndings from these studies are somewhat contradictory (Abrahao
et al., 2005; Weiser et al., 2010). Fundamental questions yet to be set-
tled include whether an association between childhood CNS infection
and adult schizophrenia really exists, whether this is conﬁned to a
particular type of infection (such as viral, bacterial or speciﬁc infec-
tious agent) (Weiser et al., 2010), and the roles of infection, inﬂam-
mation and immunity in the pathogenesis of schizophrenia (DeLisi,
1996). The effects of common childhood infections not directly affect-
ing the CNS are also unclear (Leask et al., 2002). As for prenatal infec-
tions, associations between a range of childhood infections and adult
schizophrenia would suggest that a common mechanism, possibly
Electronic search
Embase: 1470
Title and abstract screening
9 articles potentially eligible
Inclusion criteria applied
8 articles selected
Medline: 984
1 duplicate report
1 study used 
psychotic symptoms 
as outcome
Critical appraisal of individual studies
7 articles included in review
Fig. 1. Selection of studies for the review of early life infection and schizophrenia.
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important for pathogenesis of schizophrenia. Alternatively, associa-
tions with a particular infectious agent (or group) might suggest
more speciﬁc mechanisms.
We report a systematic review and meta-analyses of population-
based studies concerning early life CNS infection and risk of adult
schizophrenia and other non-affective psychosis. We summarise the
risk of psychotic illness associated with exposure to CNS infections,
overall, to viral/bacterial infections and to speciﬁc infectious agents.
We discuss associations between common childhood non-CNS infec-
tions and adult psychosis, and the effects of early life CNS infections
on neurocognitive development.
2. Methods
2.1. Search strategy
We searched Medline-PubMed and Embase databases from their
respective inceptions to February 2012 for studies based on human
samples and published in the English language. Search terms includ-
ed both indexing terms (MeSH or Key words) and free texts: [(infec-
tion OR inﬂammation OR illness OR Central Nervous System OR CNS
OR viral OR bacterial OR meningitis) AND (childhood OR early life
OR neonatal) AND (schizophrenia OR psychotic disorder)]. We also
hand searched reference lists of included studies, and wrote to prom-
inent authors for unpublished data.
2.2. Study selection
Included studies used (i) population-based cohort or case–control
designs, (ii) clinical examination and/or serology to diagnose infec-
tion at the individual level from birth until age 18 years, and (iii) con-
temporary ICD or DSM to deﬁne outcome of schizophrenia and other
psychotic disorder. Studies that used population level data, such as
prevalence of inﬂuenza, rather than direct measurement of infection
at the individual level were excluded. Studies based on neonatal
blood samples that measured speciﬁc antibodies, such as IgG to Toxo-
plasma gondii, were also excluded; such antibodies represent fetal ex-
posure to maternal infection rather than newly acquired infection
after birth.
2.3. Data extraction
Electronic search and study selection was carried out by two re-
searchers working independently (GMK and JZ). They examined all
titles and abstracts, obtained full texts of potentially relevant papers
and applied inclusion criteria. All studies meeting inclusion criteria
were critically appraised using the Newcastle–Ottawa Scale (NOS)
for assessing the quality of non-randomised studies in meta-
analyses (Wells et al., 2000). On this scale case–control and cohort
studies can earn a maximum score of 9 based on sample selection,
comparability and exposure criteria. Duplicate reports were excluded
(Gattaz et al., 2004).
2.4. Data synthesis
Meta-analysis was restricted to CNS infections as most studies in-
cluded exposure to only this type of infection. Following quality assess-
ment, we decided to combine results from three population-based
cohorts (Swedish, 1966 Finnish and 1958 British) in meta-analyses
(Leask et al., 2002; Koponen et al., 2004; Dalman et al., 2008). Out of
two available reports from the Finnish cohort the one with longer
follow-up (Koponen) was included in meta-analysis (Rantakallio et
al., 1997; Koponen et al., 2004). Remaining studies were excluded be-
cause they either did not include a control group (Suvisaari et al.,
2003), or had methodological weaknesses regarding sample selectionwhich might introduce bias (Abrahao et al., 2005; Weiser et al., 2010)
(described below).
For meta-analysis, from each study we calculated cumulative inci-
dence ratio (or risk ratio) of both non-affective psychosis and schizo-
phrenia for exposure to any CNS infection, further into viral and
bacterial infection. We used both ﬁxed and random effect models
for the calculation of pooled effect estimates. Heterogeneity between
study samples was assessed using Cochrane's heterogeneity statistic
Q (Egger et al., 2001). The I2 statistic was calculated to express the
fraction of variation between studies that was due to heterogeneity
(Higgins et al., 2003). We also carried out sensitivity analyses to ex-
amine effects of individual studies on effect estimates. Data were
analysed using Comprehensive Meta-Analysis Version 2.0 (Biostat
Inc, NJ, USA).
3. Results
We identiﬁed 7 population-based studies of early life infection
and adult schizophrenia and other psychotic disorders (Fig. 1). Indi-
vidual study characteristics including their strengths and limitations
are presented in Table 1.
3.1. Study population and control selection in studies included in review
Four studies from three population-based cohorts compared risk
of schizophrenia and other psychoses between those with a history
of childhood infection and the rest of the cohort (Rantakallio et al.,
1997; Leask et al., 2002; Koponen et al., 2004; Dalman et al., 2008).
One was a Swedish national cohort of nearly 1.2 million individuals
born between 1973 and 1985 (Dalman et al.,2008). Two reports
from the Finnish birth cohort differed only in length of follow-up
(Table 1); both were based on the same 11,017 individuals due to
be born in Northern Finland in 1966 who were alive and living in Fin-
land at age 16 years (91% of original cohort) (Rantakallio et al., 1997;
Koponen et al., 2004). Another study was based on 14,501 individuals
from the 1958 British birth cohort with information on childhood in-
fections by age 11 years (83% of original cohort) (Leask et al., 2002).
Results from these cohorts were included in meta-analyses.
One study was based on individuals who were admitted to a hos-
pital in Sao Paolo, Brazil with meningococcal meningitis during an ep-
idemic between 1971 and 1974 (Abrahao et al., 2005). Controls were
unexposed siblings who were closest in age to cases. However, this
study suffered high attrition (96%). Weiser et al. searched records of
seven hospitals that cover nearly half of the population of Israel for
cases who were hospitalised during childhood with a CNS infection
(Weiser et al., 2010). Unlike previous studies, controls were children
admitted to hospitals for acute gastroenteritis. The use of a control
Table 1
Selected population-based studies of childhood infection and schizophrenia and other psychotic disorder.
Study Design, sample and
type of infection
Outcome and
diagnostic
criteria
Age of
infection,
max
(years)
Data
source
Age at
follow up
(years)
Cumulative
incidence of
schizophrenia (%)
Adjustment
for
confounding
NOS scora
Study strengths
and limitations
Weiser et al.
(2010)
Case control: Schizophrenia,
non-affective
psychosis
and affective
disorders
by ICD 10
15 Infection:
hospital records
Mean: 29.3,
SD 6.0
CNS
infection=0.66%
Gender 5
CNS infection=3599
(414 bacterial and 3185
viral)
Outcome:
last discharge
diagnosis from
National
Psychiatric
Hospitalization
Case Registry
Range:
20–50 years
CNS Viral=0.56% Strength: large
sample
Control=6371 acute
gastroenteritis
CNS
Bacterial=1.45%
Limitations:
potential for
bias as controls
also suffered
from an infectious
illness, only used
hospitalised cases
of psychosis, short
follow up
Controls=0.75%
Dalman et al.
(2008)
Cohort study: Schizophrenia
and non-affective
psychosis by ICD 9
and ICD 10
12 Infection and
psychosis:
Swedish
National
Inpatient
Register
Range:
17–29 years
CNS
infection=0.26%b
Age, gender,
urbanicity,
parental
psychosis
7
CNS infection=8985
(2435 bacterial and
6550 viral)
CNS Viral=0.29%b Strengths: large
sample, adjusted
for important
confounders
Unexposed=1,178,586 CNS
Bacterial=0.16%b
Limitations: only
used hospitalised
cases of psychosis,
short follow up,
did not account
for attrition and
possibility of
outcome at the
time of exposure
assessment.
Unexposed=0.19%b
Abrahao et al.
(2005)
Case control: Schizophrenia
and other
psychosis
by ICD 10
4 Infection:
hospital records
Mean: 30,
SD 5.9
Meningitis=4.21% Unaffected
siblings
served as
controls
5
Meningitis=190 Outcome:
telephone
directory search
followed by
interview with
psychiatrist and
neurological
evaluation
Control=0% Strength: reliable
assessment of
outcome
Control=156 unexposed
sibling
Limitation:
small sample,
high attrition
and potential
for selection
bias
Koponen et al.
(2004)c
Birth cohort: Schizophrenia
by DSM-III-R
14 Infection:
hospital
dmission and
neurological
outpatient clinic
records
Mean: 31 CNS
infection=2.75%
Social class,
gender, perinatal
brain damage,
mental
retardation,
childhood epilepsy
7
CNS infection=145
(102 viral)
Outcome:
Finnish Hospital
Discharge
Register (FHDR)
CNS Viral=3.92% Strengths: large
sample
Unexposed=10791 CNS Bacterial=0 Limitations:
only used
hospitalised
cases of
psychosis
Unexposed=0.88%
(continued on next page)
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Table 1 (continued)
Study Design, sample and
type of infection
Outcome and
diagnostic
criteria
Age of
infection,
max
(years)
Data
source
Age at
follow up
(years)
Cumulative
incidence of
schizophrenia (%)
Adjustment
for
confounding
NOS scora
Study strengths
and limitations
Rantakallio
et al. (1997)
Birth cohort: Schizophrenia,
other psychosis
and schizophrenia
spectrum disorder
by DSM-III-R
14 Infection:
hospital
admission and
neurological
outpatient
clinic
records
Mean: 28 CNS
infection=2.75%
Social class,
gender,
perinatal brain
damage,
mental retardation,
epilepsy and
hearing deﬁcits
7
CNS infection=145
(102 viral)
Outcome:
Finnish
Hospital
Discharge
Register
CNS Bacterial=0 Strengths: large
sample
Unexposed=10872 Unexposed=0.66% Limitations: only
used hospitalised
cases of psychosis
Suvisaari et al.
(2003)
Cohort study: Schizophrenia by
ICD (8, 9 and 10)
15 Infection:
laboratory
records
Mean: 32,
SD 4.5
All CNS
viral=0.94%
– 3
CNS viral infections
(n=320)
Outcome:
Finnish
Hospital
Discharge
Register
Range:
23–41 years
Strength: reliable
assessment of
exposure
Limitation: small
sample,
no control group
used
Leask et al.
(2002)
Birth cohort: Schizophrenia and
affective psychosis
by Present State
Examination (PSE)
and CATEGO
11 Infection:
examination
by school
medical
ofﬁcer
and interview
with mother
at age 11 years
Range:
16–28 years
Meningitis: Gender and social
class
6
Childhood
infection=74d
Outcome:
National
psychiatric
hospital
admission records
Schizophrenia
group=4.34%
Strength: large
sample
Unexposed=about
12,000
Control
group=0.6%
Limitations: only
used hospitalised
cases of psychosis,
some exposure
information relied
on maternal report
a New Castle–Ottawa Scale (NOS) score, higher score represents better quality (maximum score 9).
b Non-affective psychosis including schizophrenia.
c Based on 31 year follow of the 1966 Finnish birth cohort previously reported by Rantakallio et al.
d Only study to include non-central nervous system infection in exposure; exposures included measles, chicken pox, mumps, German measles, whooping cough, scarlet fever,
infectious hepatitis, rheumatic fever, meningitis and tuberculosis.
Pooled
Pooled
Pooled
Fig. 2. Meta-analysis of childhood CNS infection and adult non-affective psychosis including schizophrenia.
164 G.M. Khandaker et al. / Schizophrenia Research 139 (2012) 161–168
Pooled
Pooled
Pooled
Fig. 3. Meta-analysis of childhood CNS infection and adult schizophrenia.
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bias (see Discussion section). Finally, the seventh study reported inci-
dence of schizophrenia among 320 individuals with laboratory con-
ﬁrmed CNS viral infection during childhood, but did not include a
control group (Suvisaari et al., 2003). These studies were excluded
from meta-analyses due to methodological issues discussed above.
3.2. Meta-analysis of childhood CNS infection and risk of later non-affective
psychoses including schizophrenia
Data was available from two cohorts (Dalman, Koponen); totalling
2424 cases and over 1.2 million controls (Fig. 2). Using a ﬁxed effect
model, only viral infection was found to be associated with a signiﬁ-
cant increase in risk, risk ratio 1.70 (95% CI 1.13–2.55; p=0.01).
There was no evidence of signiﬁcant heterogeneity between studies
(p=0.26; I2=20%). There was no statistically signiﬁcant association
between bacterial infection and adult psychosis. All results were vir-
tually unchanged using a random effect model.
3.3. Meta-analysis of childhood CNS infection and risk of later
schizophrenia
Data were available from all three eligible cohorts (Dalman,
Koponen and Leask) for this analysis, totalling 1035 cases and over
1.2 million controls (Fig. 3). However, data from the 1958 British
birth cohort was not available separately for viral and bacterial infec-
tions, and therefore, was included only in the analysis of all infections.
Using a ﬁxed effect model, nearly two-fold increased risk of adult
schizophrenia was observed for all childhood CNS infections (risk
ratio 1.80; 95% CI 1.04–3.11; p=0.03). However, there was evidence
of some heterogeneity between these studies (p=0.10; I2=55%).
Sensitivity analysis excluding Leask et al. did not change results sig-
niﬁcantly. Similar to non-affective psychosis, there was no signiﬁcantTable 2
Risk associated with speciﬁc infections.
Study Psychotic disorder Type of childhoo
Dalman et al. (2008) Non-affective psychosisa Cytomegalovirus
Mumps virus
Rantakallio et al. (1997) Schizophrenia CBV-5 meningitis
Leask et al. (2002) Schizophrenia Tuberculosisc
Affective psychosis Tuberculosisc
Chicken poxc
a Includes schizophrenia.
b Adjusted for social class and gender.
c Not CNS infection.association between bacterial CNS infection and adult schizophrenia.
However, over two-fold increased risk of adult schizophrenia was ob-
served for CNS viral infections (risk ratio 2.12; 95% CI 1.17–3.84;
p=0.01). There was evidence of some heterogeneity between these
studies (p=0.07; I2=70%).
In a separate analysis, all effect estimates fell short of statistical
signiﬁcance when a random effect model was applied. Risk ratios
for all and viral CNS infections were 2.26 (95% CI 0.88–5.84;
p=0.09) and 2.37 (95% CI 0.77–7.28; p=0.13), respectively.3.4. Speciﬁc infectious agents and schizophrenia and other psychotic
disorders
Only one study (Dalman et al.,2008) had the statistical power to
adequately examine risk associated with speciﬁc infectious agents
(Table 2). In this study half of all viral infections were caused by en-
terovirus, followed by mumps (18%) and varicella zoster (5%). At
follow-up, two out of 63 children (3%) with CNS cytomegalovirus in-
fection, and six out of 1162 (0.5%) with CNS mumps virus infection
developed non-affective psychosis (Dalman et al.,2008). None of the
other viral or bacterial infections was associated with signiﬁcant
risk of psychosis.
Coxsackie B5 virus (CBV-5) (an enterovirus)meningitis in childhood
also seemed to be associated with high incidence of adult schizophre-
nia. Between July and August 1966 there was an epidemic of CBV-5
meningitis which affected 17 newborns in Finland (Rantakallio et al.,
1970). Sixteen of these individuals were included in the 1966 Finnish
birth cohort, of which two developed schizophrenia by age 28 years
(Rantakallio et al., 1997).
Only one study examined effects of common childhood infections
with no obvious involvement of the CNS (measles, mumps, varicella,
German measles, whooping cough, scarlet fever, infectious hepatitis
and rheumatic fever) as well as meningitis and tuberculosis (Leask etd CNS infection Risk estimate (95% CI) Measure of risk
16.6 (4.30–65.10) Risk ratio
2.7 (1.20–6.20)
12.5% (−4.90%–29.90%) Cumulative incidence
15 (2.00–120.00) Odds Ratiob
12 (1.60–91.00)
0.33 (0.20–0.70)
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were reported to be associated with increased risk of schizophrenia or
other psychosis.
3.5. Characteristics of exposed individuals who developed psychotic
illness
Two general population cohorts reported detail characteristics of
individuals with adult schizophrenia or other psychosis who were ex-
posed to a CNS infection during childhood (Rantakallio et al., 1997;
Dalman et al., 2008). All of them suffered from a viral or bacterial in-
fection. In the Swedish cohort, out of 23 exposed cases 14 (60%) were
male, and 8 (35%) had a diagnosis of schizophrenia (Dalman et
al.,2008). Age at the time of infection was evenly distributed through-
out childhood (from 0 to 12.4 years) among exposed cases. Six (26%)
of these individuals had a history of substance misuse (most com-
monly cannabis) before the onset of psychotic illness (Dalman et
al.,2008).
In the 1966 Finnish birth cohort six cases were exposed (Rantakallio
et al., 1997). All four cases of schizophrenia suffered from a viral infec-
tion (two suffered from CBV-5 meningitis), while both cases of other
psychosis suffered from bacterial meningitis. Age at the time of infec-
tion among exposed cases ranged from 9 days to 7.2 years.
3.6. Neurocognitive development and childhood infection
Two birth cohorts indicate risk of adult psychotic illness following
early life CNS infection may not be directly related to childhood neu-
rological abnormalities (Rantakallio et al., 1997; Leask et al., 2002). In
the 1958 British birth cohort both adult schizophrenia and affective
psychosis was associated with increased neurological soft signs at
ages 7 and 11 years (Leask et al., 2002). Infectious illness and neuro-
logical soft sings were also correlated in the population as a whole. As
not all infection was associated with schizophrenia, this is, therefore,
unlikely that high neurological soft sign in future cases arose solely as
a result of an infection.
The 1966 Finnish birth cohort also reported more neurological ab-
normalities in the psychosis group; however, they were not related to
childhood CNS infection (Rantakallio et al., 1997). For example,
school performance at age 16 years was signiﬁcantly poorer in those
who developed a psychotic illness later in life than controls, but
cases with CNS infection did not do any worse than unexposed cases.
4. Discussion
Our meta-analysis indicates an association between childhood
CNS viral infection and risk of adult non-affective psychosis. There is
also some evidence that all childhood CNS infections, particularly
viral infections, may be associated with increased risk of adult schizo-
phrenia. These ﬁndings suggest that the vulnerable period during
which harmful events with respect to brain development may in-
crease risk of psychotic illness is not conﬁned to prenatal period
(Mednick et al., 1988; Brown and Derkits, 2010; Khandaker et al.,
2012). Studies included in our meta-analyses were large, and meth-
odologically robust. They compared risk of adult psychosis between
those who were exposed to childhood CNS infection with the rest of
the cohort, and deﬁned exposure and outcome using standard
methods. Based on representative, general population datasets the
evidence is of high quality, with good internal and external validity.
However, we acknowledge that our results are based on only two/
three cohorts as several studies were excluded due to methodological
reasons. Thus, we could not carry our formal tests for publication
bias; this cannot be ruled out and additional studies are required.
We reviewed seven population-based studies, and all except one
(Weiser) reported increased risk of adult psychosis for childhood
CNS infection. One explanation for discrepant ﬁnding from thisstudy may be bias arising from choice of controls. Unlike other stud-
ies, controls in this study also suffered from an infection (acute gas-
troenteritis) serious enough to warrant hospital admission (Weiser
et al., 2010). Interference with brain development in some controls
is possible via immunological mechanisms (discussed below).
Besides, in some controls gastroenteritis may have been caused by
undiagnosed neurotropic agents linked with the risk of psychosis. For
example, Coxsackie B5 virus (CBV-5) is highly neurotropic but can
also present with symptoms of acute gastroenteritis (Pelon et al.,
1996). Evidence suggests childhood CBV-5 infection may be related
to schizophrenia. For example, cumulative incidence of schizophrenia
among 16 individuals with childhood CBV-5 meningitis was 12.5% in
the 1966 Finnish birth cohort (Rantakallio et al., 1997). Possibility of
misclassiﬁcation of exposure in the Israeli sample also cannot be
ruled out as a speciﬁc virus/bacteria was not identiﬁed in over half
of the exposed children (Weiser et al., 2010).
In the Swedish cohort the cumulative incidence of non-affective
psychosis and schizophrenia was 0.19% and 0.07%, respectively, much
lower than the other studies included in this review. Published reports
suggest that incidence of schizophrenia and other non-affective psycho-
sis may be around 20/100 k/year (Eaton et al., 2011; Kirkbride et al.,
2012). The restriction to hospitalised cases of psychosis and relatively
short duration of follow up may explain low incidence of psychosis in
this sample. The latter is in common with most of the studies included
in this review (Table 1). Thus, future studies should allow longer
follow-up, and take measures to include schizophrenia patients who
are treated in the community (Jorgensen et al., 2010).
The 96% loss to follow-up in the Sao Paolo sample will have almost
certainly introduced bias (Abrahao et al., 2005). Overall rates of psy-
chiatric illness were unusually high in this sample (>60%). The au-
thors suggested that call to a medical review may have attracted a
sample in higher need of medical/psychiatric care. This study
reported increased risk of schizophrenia for childhood bacterial men-
ingitis, which is in contrast to ﬁndings from our meta-analysis. The
observed association in this study may be linked to higher virulence
of a pandemic meningococcal strain, or to the study methodology.
Only one study that included infections with no obvious involve-
ment of the CNS lacked power to adequately examine associations be-
tween individual infections and adult psychosis (Leask et al., 2002).
Since recent evidence points towards potentially important effects
of peripheral or systemic infections on the brain (discussed below),
in future, studies with larger samples are required.
Schizophrenia is associated with abnormalities in early neuro-
development, such as cognitive and social deﬁcit during the premorbid
period (Jones et al., 1994; Cannon et al., 2000, 2002a; Khandaker et al.,
2011a). Short and long-term neurocognitive abnormalities including
decreased verbal IQ are well documented following early life CNS infec-
tions (Christie et al., 2011). Neurological complications have also been
reported to accompany systemic infections (Khandaker et al., in press).
However, none of the studies reviewed here included any mediation
model to properly explore the effects of CNS infection on childhood
neurocognitive development and other indicators of schizophrenia.
This should be addressed in future investigations.
A range of maternal and obstetric factors have been linked with
increased risk of schizophrenia in offspring (Cannon et al., 2002b;
Khandaker et al., 2011b). In the 1966 Finnish birth cohort three out
of four cases of schizophrenia exposed to viral meningitis also experi-
enced adverse neonatal events (Rantakallio et al., 1997). The authors
accounted for perinatal brain damage in the analysis but the possibil-
ity of confounding by other factors cannot be ruled out; not least fam-
ily history of psychosis. Due to lack of individual participant data we
were unable to adjust for confounding factors in meta-analyses. How-
ever, individual studies adjusted their ﬁndings for several con-
founding factors (Table 1) such that residual confounding is unlikely
to be the sole explanation for the observed associations between
CNS infection and psychosis.
167G.M. Khandaker et al. / Schizophrenia Research 139 (2012) 161–168An association between childhood CNS viral infection and adult non-
affective psychosis indicates aetiological mechanisms related to speciﬁc
infections (or group) may be important. For example, mumps infection
was reported to be associated with increased risk of non-affective psy-
chosis in the Swedish cohort. It has been reported that certain genotypes
of the mumps virus (type C and D) exhibit greater neurovirulence than
others (genotype A) (Tecle et al., 1998). Mumps have been reported to
be associatedwith long-termdifﬁcultieswithmemory and other neuro-
logical sequelae in humans (Julkunen et al., 1985).
Maternal infection during pregnancy with T. gondii, Rubella, Cyto-
megalovirus, Herpes SimplexVirus and othermicrobes (i.e. TORCH infec-
tions) have long been known to be associated with mental retardation,
cerebral hypoplasia, ventriculomegaly, and other brain and behavioural
abnormalities in the offspring (Remington et al., 2006). For example,
congenital rubella has been linked with increased risk of schizophrenia,
including childhood IQ deﬁcit in exposed cases (Brown et al., 2001).
Thus, it is possible childhood infections with speciﬁc viral agents may
contribute towards increased risk of adult non-affective psychosis by di-
rectly interfering with brain development.
However, possible links between all CNS infections and adult
schizophrenia suggest mechanisms common to a range of infections
(such as inﬂammatory response) may also have a role. There is evi-
dence of immune dysfunction in patients with schizophrenia as
reﬂected by increased proinﬂammatory cytokine, such as interleukin
6 (IL-6) (Potvin et al., 2008). This may have links with early life infec-
tions. Increased risk of schizophrenia, and structural and functional
brain abnormalities relevant to schizophrenia have been reported
among individuals exposed to immune activation or infection during
fetal life (Brown and Derkits, 2010; Khandaker et al., 2012). Birth co-
hort studies suggest inﬂammatory cytokines may mediate the risk of
psychosis related to prenatal infection (Buka et al., 2001; Brown et al.,
2004).
There is evidence that peripheral or systemic infection can lead to
changes in cognition, mood and behaviour (Dantzer et al., 2008). Pe-
ripheral inﬂammatory cytokines, such IL-6 or TNF- α released as re-
sult of inﬂammation can communicate with the brain in a number
of ways: via the vagus nerve, active transport, or entry through leaky
circumventricular areas in the blood–brain barrier (Dantzer et al.,
2008). Once in the brain, the cytokine signal stimulates microglia to se-
crete cytokines, chemokines, and proteases from itsmonocyte andmac-
rophage linage. These local inﬂammatorymediators can affect neuronal
function and synaptic plasticity, metabolism and reuptake of neuro-
transmitters (such as, serotonin, noradrenalin and dopamine), and
stimulate the hypothalamic-pituitary-adrenal axis (Dantzer et al.,
2008). In healthy volunteers, peripheral immune activation has been
shown to increase circulating cytokines, induce anxiety and low
mood, and decrease cognitive performance (Reichenberg et al., 2001).
It has been suggested cognitive and functional decline following sys-
temic infection in older adults may be linked to the effects of systemic
proinﬂammatory response on the brain (Khandaker and Jones, 2011c).
It has been reported that areas containing previously activated mi-
croglia tend to respond more strongly to a new stimulus (Hickie et al.,
2009). Thus, childhood infection may have a priming effect on the
CNS immune system (Hickie et al., 2009). This is consistent with the
‘two hit’ model of schizophrenia (Bayer et al., 1999), whereby expo-
sure to various risk factors during early life is thought to prime the
CNS for a pathologic response to a ‘second hit’ via the same signaling
pathway (Maynard et al., 2001).
It has been suggested some genetic vulnerability to schizophrenia
may be explained by genetic vulnerability to infection (Stefansson et
al., 2009). Recently, a genome wide association study of schizophre-
nia has reported signiﬁcant associations between schizophrenia and
markers close the major histocompatibility complex region on chro-
mosome six (Stefansson et al., 2009). This region includes several im-
munity related genes as well as a histone gene cluster relevant to
gene expression; also genes involved in brain development, memoryand cognition (Stefansson et al., 2009). It is possible that infection, by
affecting gene expression or in the presence of pre-existing genetic
vulnerabilities, leads to a distinct or pathological immune response.
This may, in turn, lead to CNS alterations via cytokines and other
mechanisms making these individuals susceptible to developing psy-
chotic illness later in life. Future epidemiological studies should in-
clude genetic information as well as inﬂammatory cytokines and
other immunological markers to elucidate effects of early life infec-
tion on neurodevelopment, and risk of psychotic illness later in life.
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